Home >> Research Area >> 7-Keto-dehydroepiandrosterone

7-Keto-dehydroepiandrosterone

CAS# 566-19-8

7-Keto-dehydroepiandrosterone

Catalog No. BCC8780----Order now to get a substantial discount!

Product Name & Size Price Stock
7-Keto-dehydroepiandrosterone: 5mg $17 In Stock
7-Keto-dehydroepiandrosterone: 10mg Please Inquire In Stock
7-Keto-dehydroepiandrosterone: 20mg Please Inquire Please Inquire
7-Keto-dehydroepiandrosterone: 50mg Please Inquire Please Inquire
7-Keto-dehydroepiandrosterone: 100mg Please Inquire Please Inquire
7-Keto-dehydroepiandrosterone: 200mg Please Inquire Please Inquire
7-Keto-dehydroepiandrosterone: 500mg Please Inquire Please Inquire
7-Keto-dehydroepiandrosterone: 1000mg Please Inquire Please Inquire

Quality Control of 7-Keto-dehydroepiandrosterone

Number of papers citing our products

Chemical structure

7-Keto-dehydroepiandrosterone

3D structure

Chemical Properties of 7-Keto-dehydroepiandrosterone

Cas No. 566-19-8 SDF Download SDF
PubChem ID 193313 Appearance Powder
Formula C19H26O3 M.Wt 302.4
Type of Compound N/A Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-2,3,4,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-7,17-dione
SMILES CC12CCC3C(C1CCC2=O)C(=O)C=C4C3(CCC(C4)O)C
Standard InChIKey KPRGOTLNGIBVFL-GINZOMEDSA-N
Standard InChI InChI=1S/C19H26O3/c1-18-7-5-12(20)9-11(18)10-15(21)17-13-3-4-16(22)19(13,2)8-6-14(17)18/h10,12-14,17,20H,3-9H2,1-2H3/t12-,13-,14-,17-,18-,19-/m0/s1
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

7-Keto-dehydroepiandrosterone Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

7-Keto-dehydroepiandrosterone Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of 7-Keto-dehydroepiandrosterone

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.3069 mL 16.5344 mL 33.0688 mL 66.1376 mL 82.672 mL
5 mM 0.6614 mL 3.3069 mL 6.6138 mL 13.2275 mL 16.5344 mL
10 mM 0.3307 mL 1.6534 mL 3.3069 mL 6.6138 mL 8.2672 mL
50 mM 0.0661 mL 0.3307 mL 0.6614 mL 1.3228 mL 1.6534 mL
100 mM 0.0331 mL 0.1653 mL 0.3307 mL 0.6614 mL 0.8267 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on 7-Keto-dehydroepiandrosterone

The clinical use of dehydroepiandrosterone in postmenopausal women.[Pubmed:23965649]

Int J Pharm Compd. 2010 Nov-Dec;14(6):465-71.

A basic understanding of the distinct metabolism, mechanism of action, and clinical use of dehydroepiandrosterone and its metabolites is critical to balancing the hormone milieu in postmenopausal women. To date, studies of dehydroepiandrosterone therapy in women with adrenal insufficiency suggest that they are the most likely group to gain health benefits from dehydroepiandrosterone replacement therapy. Our understanding of the potential long-term health benefits of replacing dehydroepiandrosterone along with other deficient hormones is still only in its infancy. With the evidence currently available, however, one can reasonably suggest that dehydroepiandrosterone offers the promise of a safe and efficient replacement therapy for specific symptoms common to postmenopausal women. This article reviews the metabolism, physiology, and clinical use of dehydroepiandrosterone in postmenopausal women. The clinical effectiveness of dehydroepiandrosterone for vulvovaginal atrophy, sexual dysfunction, osteoporosis, adrenal and immunological function, cardiovascular disease, and, in combination, hormone replacement therapy is reviewed. In addition, the use of the dehydroepiandrosterone metabolite 7-Keto-dehydroepiandrosterone for weight loss is discussed.

[Effect of chorionic gonadotropin on the urinary excretion of testosterone and other androgens in healthy men and those with coronary arteriosclerosis].[Pubmed:156806]

Kardiologiia. 1979 Jun;19(6):76-9.

The results of studying the excretion of testosterone and other androgens with the urine after a chorionic gonadotropin load in patients with ischemic heart disease and in persons who had suffered from acute myocardial infarction are discussed. In choriogonin load stimulating the gonads, there is noticeable variability in the excretion of testosterone and epitestosterone, androstenedione, and 7-Keto-dehydroepiandrosterone in the urine. The data obtained are evidence of reduced functional reserves of the sex glands in some of the patients.

Keywords:

7-Keto-dehydroepiandrosterone,566-19-8,Natural Products, buy 7-Keto-dehydroepiandrosterone , 7-Keto-dehydroepiandrosterone supplier , purchase 7-Keto-dehydroepiandrosterone , 7-Keto-dehydroepiandrosterone cost , 7-Keto-dehydroepiandrosterone manufacturer , order 7-Keto-dehydroepiandrosterone , high purity 7-Keto-dehydroepiandrosterone

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: